NCT06712342

Brief Summary

The effectiveness of upper extremity focused neuromuscular exercise training in early stage people with MS will be investigated. People with MS enrolled in the study will be randomly assigned to three groups: Neuromuscular Exercise Group (NEG), Conventional Exercise Group (CEG), and Control Group (CG). All three groups will be assessed with primary and secondary outcome measures at baseline, week 8, and week 12. NEG, CEG, and CG will be initially assessed for upper extremity function, cognitive function, lower extremity function, grip strength, proximal muscle strength, sensation, coordination, fatigue, postural sway, and core muscle strength and endurance. Then, NEG will receive clinically supervised upper extremity focused neuromuscular exercise training with a minimum of 60 minutes of session time, 2 days a week for 8 weeks. This exercise training includes steps for postural control, weight transfer, proximal and distal muscle strengthening, proprioception, coordination and reaction speed. Similarly, CEG will receive clinically supervised traditional upper extremity exercise training, twice a week for 8 weeks, with a minimum of 60 minutes of session time. This exercise training includes strengthening with the band and manuel dexterity exercises. In both groups, stretching and mobility exercises will be added to the warm-up and cool-down exercises before and after the program. During this process, CG will be on the waiting list. At the end of 8 weeks, all three groups will be re-evaluated. After the exercise training, follow-up will be done and evaluations will be repeated in the 12th week. This study will provide evidence on the effects of upper extremity-focused neuromuscular exercise training on physical and cognitive functions in early-stage people with MS compared to traditional treatment approaches.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Nov 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

November 30, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 2, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2025

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

11 months

First QC Date

November 26, 2024

Last Update Submit

December 1, 2024

Conditions

Keywords

Multiple Sclerosisexercisefunctionupper extremityneuromuscular exercise trainingmanual dexterity

Outcome Measures

Primary Outcomes (6)

  • Nine Hole Peg Test

    To assess unilateral function of the upper extremity

    At the beginning, at the end of 8 weeks and 12 weeks

  • Minnesota Manual Dexterity Test

    To assess bilateral upper extremity function

    At the beginning, at the end of 8 weeks and 12 weeks

  • Manual Ability Measure-36

    To assess upper extremity function. A higher score indicates better hand function.

    At the beginning, at the end of 8 weeks and 12 weeks

  • Timed 25-Foot Walk

    To assess lower extremity function

    At the beginning, at the end of 8 weeks and 12 weeks

  • Symbol Digit Modalities Test

    To assess cognitive function

    At the beginning, at the end of 8 weeks and 12 weeks

  • Hand Dynamometer

    To assess hand grip strength

    At the beginning, at the end of 8 weeks and 12 weeks

Secondary Outcomes (7)

  • Hand Held Dynamometer

    At the beginning, at the end of 8 weeks and 12 weeks

  • Biodex Balance System

    At the beginning, at the end of 8 weeks and 12 weeks

  • Laser-pointer Assisted Angle Reproduction Test

    At the beginning, at the end of 8 weeks and 12 weeks

  • Finger Tapping Test

    At the beginning, at the end of 8 weeks and 12 weeks

  • Fatigue Severity Scale

    At the beginning, at the end of 8 weeks and 12 weeks

  • +2 more secondary outcomes

Study Arms (3)

NEG

EXPERIMENTAL

Upper Extremity Focused Neuromuscular Exercise Training

Other: Neuromuscular Exercise Training

CEG

ACTIVE COMPARATOR

Traditional Upper Extremity Exercise Training

Other: Conventional Exercise Training

CG

NO INTERVENTION

Control Group

Interventions

This group will receive neuromuscular exercise training with 60-75 minute sessions per day, 2 days a week, for 8 weeks. Warm-up Program - 5 minutes Postural Control-Weight Transfer - 10-15 minutes Strength Training - 30-35 minutes Proprioception - Coordination - Reaction Speed 10-15 minutes Cool-down Program - 5 minutes

NEG

This group will be given traditional strength exercise training consisting of 60-75 minute sessions per day, 2 days per week for 8 weeks. Warm-up Program - 5 minutes Strength Training - 30-35 minutes Manuel Dexterity - 15-20 minutes Cool-down Program - 5 minutes

CEG

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Definite MS according to McDonald criteria,
  • years
  • RRMS,
  • EDSS \< 4,
  • Minimal or moderate upper extremity involvement

You may not qualify if:

  • Having an attack in the last three months,
  • Mini Mental Test \<24 or visual deficit,
  • Other medical conditions accompanying MS (cardiac, orthopedic or rheumatic, etc.),
  • Being pregnant or breastfeeding,
  • Doing regular exercise - receiving physiotherapy,
  • Having spasticity of 2 or more in the upper extremity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Study Officials

  • Uğur Ovacık

    Istanbul Aydın University

    PRINCIPAL INVESTIGATOR
  • Ela Tarakcı

    Istanbul University - Cerrahpasa

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PT, MSc

Study Record Dates

First Submitted

November 26, 2024

First Posted

December 2, 2024

Study Start

November 30, 2024

Primary Completion

November 1, 2025

Study Completion

December 29, 2025

Last Updated

December 4, 2024

Record last verified: 2024-12